EPH85 Real-World Temporal and Indication-Specific Variation in Drivers of GLP-1 RA DiscontinuationB Cartwright, N. Stucky, Duy Ngoc et al.|Value in Health|2025Cited by 0
EPH49 Characteristics and Adherence of Patients Initiating Injectable Cabotegravir for HIV Treatment or PreventionDuy Do, N. Stucky, Patricia J. Rodriguez et al.|Value in Health|2025Cited by 0